Prim SA
Prim SA is a medical equipment and supplies company that generates revenue through the distribution and sale of healthcare products and services.
Business. Prim SA (PRIM.MC) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, including capital equipment and consumables. Prim SA is headquartered in Spain and is primarily listed on the BME (Madrid) exchange. Specific details regarding its operating segments and geographic mix are not disclosed.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
- Congressional trades
- CongressJosh Gottheimer — Primoris Services Corporation2024-12-06 · Democrat · NJ · Sale · $1,001 - $15,000
- CongressJosh Gottheimer — Primoris Services Corporation2024-06-27 · Democrat · NJ · Sale · $1,001 - $15,000
- CongressJosh Gottheimer — Primoris Services Corporation2024-06-21 · Democrat · NJ · Sale · $1,001 - $15,000
- CongressJosh Gottheimer — Primoris Services Corporation2023-10-27 · Democrat · NJ · Sale · $1,001 - $15,000
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Prim SA (PRIM.MC) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue through the sale of products, including capital equipment and consumables. Prim SA is headquartered in Spain and is primarily listed on the BME (Madrid) exchange. Specific details regarding its operating segments and geographic mix are not disclosed.
Prim SA maintains a conservative capital structure with a debt-to-equity ratio of 0.11, indicating a low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 2.99, suggesting strong short-term liquidity. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints.
In terms of profitability, Prim SA reports a return on equity (ROE) of 12.12% and a return on assets (ROA) of 8.49%. These figures are to be compared against the industry's preferred metrics, which typically emphasize operational efficiency and consistent revenue generation. The company's operating income of 22,075,470 EUR and net income of 16,683,360 EUR reflect a healthy margin, but the extent to which these compare to industry medians remains to be determined.
Prim SA's revenue is primarily derived from its core operations in the medical equipment and supplies sector, with no specific geographic or segment breakdown provided in the available data. The absence of detailed segmental or geographic revenue data limits the ability to assess exposure to specific markets or product lines.
The company's growth trajectory is supported by a positive free cash flow of 8,002,480 EUR and a capital expenditure of -12,317,900 EUR, indicating a net outflow for capital investments. Analysts have assigned a mean recommendation of 1.00, which is the highest score on the scale, suggesting strong confidence in the company's future performance.
The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's dilution potential is considered low, and no significant adjustments have been applied to the valuation metrics. The absence of recent filings or transcripts prevents a detailed analysis of recent events that could impact the company's operations or financial position.
- Prim SA has a strong current ratio of 2.99, indicating robust short-term liquidity.
- The company's ROE of 12.12% and ROA of 8.49% suggest solid profitability.
- Analysts have given a mean recommendation of 1.00, indicating strong buy sentiment.
- The company's capital structure is conservative, with a debt-to-equity ratio of 0.11.
- Free cash flow is positive at 8,002,480 EUR, supporting potential growth initiatives.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 1,16 |
| Revenue | —no estimate | —no estimate | 271,0M EUR |
| Operating income | —no estimate | —no estimate | 26,0M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Restricted Stock Units → Common StockDisposed 21 774exercise · 2026-04-01
- CHIEF OPERATING OFFICER · Restricted Stock Units → Common StockDisposed 244exercise · 2026-04-01
- CHIEF OPERATING OFFICER · Restricted Stock Units → Common StockDisposed 6 023exercise · 2026-03-01
- CHIEF LEGAL AND ADMIN OFFICER · Restricted Stock Units → Common StockDisposed 12 290exercise · 2026-03-01
- CHIEF LEGAL AND ADMIN OFFICER · Restricted Stock Units → Common StockAcquired 2 723grant · 2026-03-01
- CHIEF FINANCIAL OFFICER · Restricted Stock Units → Common StockDisposed 10 522exercise · 2026-03-01
- CHIEF OPERATING OFFICER · Restricted Stock Units → Common StockAcquired 2 323grant · 2026-03-01
- CAO · Restricted Stock Units → Common StockAcquired 930grant · 2026-03-01
- CHIEF FINANCIAL OFFICER · Restricted Stock Units → Common StockAcquired 2 140grant · 2026-03-01
- Director, PRESIDENT & CEO · Restricted Stock Units → Common StockAcquired 6 967grant · 2026-03-01
- CAO · Restricted Stock Units → Common StockDisposed 4 758exercise · 2026-03-01
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Prim SA Market data — financials · 2026-05-29
- Prim SA Market data — analyst estimates · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,29 %$413M
- Investment Managers · as of 2026-03-310,08 %$154M
- Investment Managers · as of 2026-03-310,05 %$269M
- Investment Managers · as of 2026-03-310,03 %$166M
- Funds · as of 2026-03-310,03 %$200M
- Investment Managers · as of 2026-03-310,03 %$85M
- Investment Managers · as of 2026-03-310,03 %$49M
- Institutional Investor · as of 2026-03-310,02 %$54M
- Investment Managers · as of 2026-03-310,02 %$85M
- Investment Managers · as of 2026-03-310,01 %$98M
- Brokerage Firms · as of 2026-03-310,01 %$47M
- Investment Managers · as of 2026-03-310,01 %$106M
- Investment Managers · as of 2026-03-310,01 %$208M
- Investment Managers · as of 2024-12-310,01 %$43M
- Investment Managers · as of 2026-03-310,01 %$0M
- Investment Managers · as of 2025-12-310,01 %$804M
- Investment Managers · as of 2026-03-310,01 %$16M
- Investment Managers · as of 2026-03-310,01 %$295M
- Investment Managers · as of 2026-03-310,01 %$74M
- Institutional Investor · as of 2026-03-310,01 %$49M
- Institutional Investor · as of 2026-03-310,01 %$39M
- Investment Managers · as of 2026-03-310,01 %$16M
- Brokerage Firms · as of 2026-03-310,01 %$35M
- Investment Managers · as of 2024-06-300,01 %$257M
- Institutional Investor · as of 2026-03-310,01 %$101M
- Investment Managers · as of 2026-03-310,00 %$79M
- Investment Managers · as of 2026-03-310,00 %$10M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
Leadership
- Thomas Edward McCormickPresident, Chief Executive Officer, Director
Insider activity
- Director · Common StockOther 356 · 2026-07-31
- Director · Common StockOther 356 · 2026-07-31
- Director · Common StockOther 356 · 2026-07-31
- Director · Common StockOther 356 · 2026-07-31
- Director · Common StockOther 356 · 2026-07-31
- Director · Common StockOther 356 · 2026-07-31
- Director · Common StockOther 356 · 2026-07-31
- Director · Common StockBought 20 @ $86,66$2K · 2026-07-15
- CHIEF LEGAL AND ADMIN OFFICER · Common StockSold 2 133 @ $125,75$268K · 2026-05-28
- CHIEF LEGAL AND ADMIN OFFICER · Common StockSold 9 450 @ $126,68$1,2M · 2026-05-28
- CHIEF LEGAL AND ADMIN OFFICER · Common StockSold 6 017 @ $127,66$768K · 2026-05-28
- CHIEF LEGAL AND ADMIN OFFICER · Common StockSold 6 147 @ $128,65$791K · 2026-05-28
- CHIEF LEGAL AND ADMIN OFFICER · Common StockSold 5 855 @ $129,85$760K · 2026-05-28
- CHIEF LEGAL AND ADMIN OFFICER · Common StockSold 105 @ $130,26$14K · 2026-05-28
- Director, PRESIDENT & CEO · Common StockOther 7 815 @ $127,96$1,0M · 2026-05-27
- Director · Common StockSold 12 333 @ $118,55$1,5M · 2026-05-26
- Director · Common StockSold 3 917 @ $119,66$469K · 2026-05-26
- Director · Common StockSold 3 750 @ $120,27$451K · 2026-05-26
- Director · Common StockOther 268 · 2026-04-30
- Director · Common StockOther 268 · 2026-04-30
- Director · Common StockOther 268 · 2026-04-30
- Director · Common StockOther 268 · 2026-04-30
- Director · Common StockOther 268 · 2026-04-30
- Director · Common StockOther 268 · 2026-04-30
- Director · Common StockOther 268 · 2026-04-30
Short positioning
Held by funds 1
- BlackRock (iShares) · ETF0,50 %80,0B $ · #36
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 19.3%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 5.1%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -2.1%Derived (calculated)
- Gross margin (FY 2025-12-31): 10.7%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.26xDerived (calculated)
- Return on assets (FY 2025-12-31): 6.2%Derived (calculated)
- Return on equity (FY 2025-12-31): 16.4%Derived (calculated)
- Net margin (FY 2025-12-31): 3.6%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 19.0%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 29.6%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -7.5%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 52.0%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -36.1%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): 15.6%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 51.7%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 51.0%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 19.4%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 17.5%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 2.7%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 1.62xDerived (calculated)
- Current liabilities (annual): USD 1.85BSEC XBRL filing
- Total liabilities (annual): USD 2.73BSEC XBRL filing
- Operating cash flow (annual): USD 470.4MSEC XBRL filing
- Total assets (annual): USD 4.41BSEC XBRL filing